| Particulars |
| Company Name |
Goldline Pharmaceutical Ltd |
Year End |
202603 |
| Full Year |
| Equity (Rs Cr.) |
9.60 |
B.V. Rs |
25.10 |
| Sales Rs Cr. |
31.20 |
NP Rs Cr. |
4.12 |
| NP Var% |
42.00 |
Div% |
0.00 |
| CPS Rs |
4.50 |
EPS Rs |
4.30 |
| Traded Value(Rs Lakhs) |
86.08 |
52 Week High |
60.00 |
| 52 Week Low |
33.00 |
Price BSE |
41.00 |
| Price NSE |
0.00 |
Market Capital(Rs Cr.) |
39.33 |
| P/C Ratio |
9.00 |
P/E Ratio |
9.60 |
| Price Vs.BV |
1.63 |
|
| Latest Quarter |
| Year End |
202603 |
Sales Rs Cr. |
9.79 |
| NP Rs Cr. |
1.89 |
NP Var % |
0.00 |
| Trailing Twelve Months |
| Year End |
0 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var% |
|
EPS |
0.00 |
| PE |
0.00 |
|
|